| 390. | Vatsiou, S., Zamanakou, M., Loules, G., Psarros, F., Parsopoulou, F., Csuka, D., Valerieva, A., Staevska, M., Porebski, G., Obtulowicz, K., Magerl, M., Maurer, M., Speletas, M., Farkas, H., and Germenis, A. E.+: A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency. Allergol. Int. 2020: 69; 443-449. IF: 5.84 |
o.390
| 234 | Longhurst, H. J.+, Aberer, W., Bouillet, L., Caballero, T., Maurer, M. Fabien, V., Zanichelli, A.: The icatibant outcome survey: treatment of laryngeal angioedema attacks. Eur. J. Emerg. Med. 2016: 23; 224-227. IF: 2.02 |
The icatibant outcome survey: treatment of laryngeal angioedema attacks Read More »
| 225 | Speletas, M., Szilagyi, A., Csuka, D., Koutsostathis, N., Psarros, F., Moldovan, D., Magerl, M., Kompoti, M., Varga, L., Maurer, M. Farkas, H., and Germenis, A. E.+: F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema. Allergy 2015: 70; 1661-1664. IF: 6.33 |
F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema Read More »
| 212 | Hernández Fernández de Rojas, D.+, Ibáňez, E., Longhurst, H., Maurer, M. Fabien, V., Aberer, W., Bouillet, L., Zanichelli, A., and Caballero, T.: Treatment of HAE attacks in the icatibant outcome survey: an analysis of icatibant self-administration versus administration by health care professionals. Int. Arch. Allergy Immunol. 2015: 167; 21-28. IF: 2.67 |
| 289 | Gianni, P., Loules, G., Zamanakou, M., Kompoti, M., Csuka, D., Psarros, F., Magerl, M., Moldovan, D., Maurer, M. Speletas, M. G., Farkas, H., and Germenis, A. E.+: Genetic determinants of C1 inhibitor deficiency angioedema age of onset. Int. Arch. Allergy Immunol. 2017: 174; 200-204. IF: 2.44 |
Genetic determinants of C1 inhibitor deficiency angioedema age of onset Read More »
| 337 | Bork, K.+, Aygören-Pürsün, E., Bas, M., Biedermann, T., Greve, J., Hartmann, K., Magerl, M., Martinez-Saguer, I., Maurer, M., Ott, H., Schauf, L., Staubach, P., and Wedi, B.: Guideline: Hereditary angioedema due to C1 inhibitor deficiency. S1-Guideline of the German Society for Angioedema (DGA), German Society for Internal Medicine (DGIM), German Society for Otorhinolaryngology (DGHNO), German Society for Allergology and Clinical Immunology (DGAKI), German Society for Child and Adolescent Medicine (DGKJ), German Dermatological Society (DDG), German Society for Pediatric Allergology and Environmental Medicine (GPA), German Association of ENT Surgeons (BVHNO) and the German HAE Patient Association (HAE-SHG). Allergo J. Int. 2019: 28; 16-29. IF: 2.06 |